These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7506314)

  • 1. PSA and the detection of prostate cancer.
    Robbins AS
    JAMA; 1994 Jan; 271(3):192-3. PubMed ID: 7506314
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Public knowledge of benefits of breast and prostate cancer screening in Europe.
    Brenner H; Heywang-Köbrunner S; Becker N
    J Natl Cancer Inst; 2010 Mar; 102(5):356; author reply 356-7. PubMed ID: 20075365
    [No Abstract]   [Full Text] [Related]  

  • 4. PSA and prostate cancer diagnosis.
    Savage P; Waxman J
    Eur J Cancer; 1996 Jun; 32A(7):1097-9. PubMed ID: 8758236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
    Borkowetz A
    Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostate cancer screening: no proof of the benefit].
    Laplanche A; Hill C
    Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of prostate specific antigen (PSA) and carcinoembryonic antigen (CEA) in screening for prostate and recurrent colon cancers in the elderly.
    Vandenberg TA
    Clin Biochem; 1993 Dec; 26(6):429-30. PubMed ID: 7510220
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estimating standard performance measures of opportunistic screening for prostate cancer].
    Leoni M; Falcini F; Ravaioli A; Foca F; Andalò G; Benini F; Dal Pozzo C; Ricci R; Naldoni C; Bucchi L
    Epidemiol Prev; 2008; 32(6):285-93. PubMed ID: 19353962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostate cancer].
    Huland H; Wirth M
    Urologe A; 2000 Jan; 39(1):2. PubMed ID: 10663188
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate specific antigen through the years.
    Kouriefs C; Sahoyl M; Grange P; Muir G
    Arch Ital Urol Androl; 2009 Dec; 81(4):195-8. PubMed ID: 20608139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.
    Morgan T; Palapattu G; Wei J
    Curr Urol Rep; 2015 Sep; 16(9):63. PubMed ID: 26169584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numbers needed to decide.
    Woloshin S; Schwartz LM
    J Natl Cancer Inst; 2009 Sep; 101(17):1163-5. PubMed ID: 19671771
    [No Abstract]   [Full Text] [Related]  

  • 15. Conditions associated with normal levels of prostate-specific antigen and elevation of prostatic acid phosphatase.
    Lloyd AJ; Formby MR
    Am J Clin Oncol; 1992 Dec; 15(6):487-9. PubMed ID: 1280403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
    Kato M; Okada K
    Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients Present with More Advanced Prostate Cancer since the USPSTF Screening Recommendations.
    Barry MJ; Nelson JB
    J Urol; 2015 Dec; 194(6):1534-6. PubMed ID: 26384450
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical malpractice implications of PSA testing for early detection of prostate cancer.
    Collins MM; Fowler FJ; Roberts RG; Oesterling JE; Annas GJ; Barry MJ
    J Law Med Ethics; 1997; 25(4):234-42, 230. PubMed ID: 11066505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for prostate cancer in Dutch hereditary prostate cancer families.
    Kiemeney LA; Broeders MJ; Pelger M; Kil PJ; Schröder FH; Witjes JA; Vasen HF
    Int J Cancer; 2008 Feb; 122(4):871-6. PubMed ID: 17957791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostate cancer utilizing the prostate-specific antigen (PSA).
    Halperin EC
    N C Med J; 1993 Sep; 54(9):443-6. PubMed ID: 7694161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.